Thursday, Jan 01st
Last update05:32:04 AM GMT
Eli Lilly & Co. trained its sales force to downplay risks for Zyprexa and encourage doctors to prescribe the drug beyond approved uses for schizophrenia and bipolar disorder, according to court documents.
Lilly's research showed some patients on Zyprexa gained as much as 80 pounds and that the incidence of high blood sugar at diabetes levels was 3.5 times higher than for placebos, according to documents filed in a lawsuit brought by the state of Alaska.
 The Department of Health and Human Services is freezing all childcare payments to all states, an... |
 US regulators on Monday gave the green light to a pill version of the blockbuster weight-loss... | ||
 Eileen Schoch traveled to her mother's funeral in Asheville, N.C. and found the hotel room —... |
Dr. Kade Goepferd watched the Trump administration's moves on Thursday to ban gender-affirming care for transgender... |
